Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of metformin HC1 750
mg extended-release tablets (Ranbaxy) with that of Glucophage® XR 750 mg tablets (Bristol
Myers Squibb) in healthy, adult, subjects under non-fasting conditions.